Dr. Karen Reckamp of City of Hope Cancer Center reviews the concept of acquired resistance to targeted therapies in patients with a driver mutation and why it occurs.
Advertisement
What is Acquired Resistance to Targeted Therapy, and Why Does it Occur_ [360p]
